loader2
Partner With Us NRI

Norris Medicines Ltd share Price Today

Company details

12.71
13.60
10.00
27.51
6M Return 16.24%
1Y Return 29.40%
Mkt Cap.(Cr) 13.60
Volume 1,131
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 1,131

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Norris Medicines Ltd shares SWOT Analysis

Strengths (7)

  • Rising Net Cash Flow and Cash from Operating activity
  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Weakness (7)

  • Red Flag: High Interest Payments Compared to Earnings
  • Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
  • Low Piotroski Score : Companies with weak financials

Opportunity (2)

  • Positive Breakout First Resistance ( LTP > R1)
  • Stock with Low PE (PE < = 10)

Threats (0)

Data not found

Resistance and support

R1 13.9
R2 14.2
R3 14.8
Pivot

13.30

S1 13.0
S2 12.4
S3 12.1
EMA SMA
15.3
17.2
16.6
15.2
15.5
19.8
16.4
14.0
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
Name Category Shares
VIMAL D SHAH PROMOTER 23.6%
NAVSARJAN INVESTMENT & TRADING PVT LTD PROMOTER 10%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Norris Medicines Ltd Stocks COMPARISON

Financials( in Cr) Norris Medicines Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Zydus Lifesciences Ltd
Price 13.60 1,620.55 1,496.95 6,157.90 1,007.35
% Change 4.86 1.02 2.30 1.88 0.77
Mcap Cr 13.60 388,824.23 120,856.26 102,719.31 101,964.37
Revenue TTM Cr 8.36 43,885.68 15,790.60 24,669.70 17,237.40
Net Profit TTM Cr -1.75 8,560.84 2,513.47 4,507.30 1,997.30
PE TTM 0.00 41.13 29.93 19.30 30.34
1 Year Return 29.40 64.78 68.33 37.28 109.04
ROCE 0.00 16.79 14.76 25.99 16.25
ROE 0.00 16.46 10.66 21.21 14.05
INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: -12.44 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 30,755.54 31,723.05
LAST 3M 69,913.40 26,515.65
LAST 6M 130,081.93 60,306.69
LAST 12M 189,259.39 205,003.99

Norris Medicines Ltd Information

Stock PE (TTM)
0
Promoter Holding
34.01%
Book Value
-13.4584
ROCE
0%
ROE
0%
Description
  • Norris Medicines Ltd was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on 7th March 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.`91. The project commence in March 1992. Thereafter, the Company came out with a Public Issue aggregating Rs 5 cr in Dec.`93 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity, which got completed in 1995. In 2006, the Company launched Diabetic & Cardiac products; launched Dental product in 2007; launched New Molecule Tolperisone with Paracetamol tablet in 2012; in 2013, it extended Anti malarial range with Artemether Lumefantrine tablet & dry syrup. During the year 2013-14, the Company undertook the upgradation of Sterile Injectable Plant. The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and has 2 plants situated at GIDC, Ankleshwar, Gujarat. Both plants of the Company are WHO cGMP approved. At present, it has renovated the Sterile Injectable Plant, which is as per international standards.

Registered Address

Plot No 801/P & 802, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002

Tel : 91-2646-223462/227530
Email : norrismedicines:gmail.com; contact:norrispharma.co
Website : http://www.norrispharma.com
Registrar

Norris Medicines Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524414
NSE Code :
Book Closure Date (Month) : Dec
BSE Group : XT
ISIN : INE744C01029

FAQ’s on Norris Medicines Ltd Shares

You can buy Norris Medicines Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Norris Medicines Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Mar 28, 2024 04:01 PM the closing price of Norris Medicines Ltd was ₹ 13.60.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 28, 2024 04:01 PM, the market cap of Norris Medicines Ltd stood at ₹ 13.60.

The latest PE ratio of Norris Medicines Ltd as of Mar 28, 2024 04:01 PM is 0

The latest PB ratio of Norris Medicines Ltd as of Mar 28, 2024 04:01 PM is -1.01

The 52-week high of Norris Medicines Ltd share price is ₹ 27.51 while the 52-week low is ₹ 10.00

Download Our

Download App
market app